nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—BCL2—head and neck cancer	0.148	0.605	CbGaD
Docetaxel—melanoma—head and neck cancer	0.127	0.35	CtDrD
Docetaxel—stomach cancer—head and neck cancer	0.119	0.325	CtDrD
Docetaxel—skin cancer—head and neck cancer	0.119	0.325	CtDrD
Docetaxel—EGFR—head and neck cancer	0.097	0.396	CbGaD
Docetaxel—TUBB8—Vinblastine—head and neck cancer	0.0307	0.105	CbGbCtD
Docetaxel—TUBB2B—Vinblastine—head and neck cancer	0.0307	0.105	CbGbCtD
Docetaxel—TUBB4A—Vinblastine—head and neck cancer	0.0307	0.105	CbGbCtD
Docetaxel—TUBB3—Vinblastine—head and neck cancer	0.0307	0.105	CbGbCtD
Docetaxel—TUBB2A—Vinblastine—head and neck cancer	0.0307	0.105	CbGbCtD
Docetaxel—TUBB6—Vinblastine—head and neck cancer	0.0307	0.105	CbGbCtD
Docetaxel—TUBB1—Vinblastine—head and neck cancer	0.0256	0.0876	CbGbCtD
Docetaxel—TUBB4B—Vinblastine—head and neck cancer	0.0256	0.0876	CbGbCtD
Docetaxel—TUBB—Vinblastine—head and neck cancer	0.0256	0.0876	CbGbCtD
Docetaxel—SLC22A7—Fluorouracil—head and neck cancer	0.0104	0.0355	CbGbCtD
Docetaxel—ABCC1—Vinblastine—head and neck cancer	0.00756	0.0258	CbGbCtD
Docetaxel—ABCC2—Vinblastine—head and neck cancer	0.0056	0.0191	CbGbCtD
Docetaxel—ABCG2—Fluorouracil—head and neck cancer	0.00546	0.0187	CbGbCtD
Docetaxel—Metastatic disease—Hydroxyurea—head and neck cancer	0.00225	0.0592	CcSEcCtD
Docetaxel—Onychomadesis—Fluorouracil—head and neck cancer	0.00224	0.059	CcSEcCtD
Docetaxel—Acute pulmonary oedema—Fluorouracil—head and neck cancer	0.00198	0.0521	CcSEcCtD
Docetaxel—ABCB1—Vinblastine—head and neck cancer	0.00183	0.00623	CbGbCtD
Docetaxel—Recall phenomenon—Hydroxyurea—head and neck cancer	0.0015	0.0394	CcSEcCtD
Docetaxel—Metastatic neoplasm—Hydroxyurea—head and neck cancer	0.00135	0.0356	CcSEcCtD
Docetaxel—Paclitaxel—BCL2—head and neck cancer	0.00129	1	CrCbGaD
Docetaxel—Nail changes—Fluorouracil—head and neck cancer	0.00129	0.0339	CcSEcCtD
Docetaxel—CYP3A4—Vinblastine—head and neck cancer	0.00109	0.00373	CbGbCtD
Docetaxel—Neutropenic sepsis—Fluorouracil—head and neck cancer	0.00108	0.0283	CcSEcCtD
Docetaxel—Cardiotoxicity—Fluorouracil—head and neck cancer	0.000793	0.0209	CcSEcCtD
Docetaxel—MAP4—hair follicle—head and neck cancer	0.000727	0.0387	CbGeAlD
Docetaxel—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.000697	0.0183	CcSEcCtD
Docetaxel—Myelosuppression—Vinblastine—head and neck cancer	0.000607	0.016	CcSEcCtD
Docetaxel—Pulmonary fibrosis—Hydroxyurea—head and neck cancer	0.00059	0.0155	CcSEcCtD
Docetaxel—Myelosuppression—Hydroxyurea—head and neck cancer	0.000554	0.0146	CcSEcCtD
Docetaxel—GHRHR—head—head and neck cancer	0.000526	0.0279	CbGeAlD
Docetaxel—BCL2—mouth—head and neck cancer	0.000519	0.0276	CbGeAlD
Docetaxel—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.000469	0.0123	CcSEcCtD
Docetaxel—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.000469	0.0123	CcSEcCtD
Docetaxel—BCL2—neck—head and neck cancer	0.000443	0.0236	CbGeAlD
Docetaxel—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.000436	0.0115	CcSEcCtD
Docetaxel—Dysaesthesia—Fluorouracil—head and neck cancer	0.000432	0.0114	CcSEcCtD
Docetaxel—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.000431	0.0113	CcSEcCtD
Docetaxel—Eruption—Hydroxyurea—head and neck cancer	0.000422	0.0111	CcSEcCtD
Docetaxel—TUBB—hair follicle—head and neck cancer	0.000405	0.0215	CbGeAlD
Docetaxel—Ileus—Vinblastine—head and neck cancer	0.000402	0.0106	CcSEcCtD
Docetaxel—Myelosuppression—Fluorouracil—head and neck cancer	0.000398	0.0105	CcSEcCtD
Docetaxel—MAP2—neck—head and neck cancer	0.000384	0.0204	CbGeAlD
Docetaxel—Neuritis—Vinblastine—head and neck cancer	0.000381	0.01	CcSEcCtD
Docetaxel—MAP4—connective tissue—head and neck cancer	0.00035	0.0186	CbGeAlD
Docetaxel—TUBB3—connective tissue—head and neck cancer	0.00035	0.0186	CbGeAlD
Docetaxel—TUBB4B—hair follicle—head and neck cancer	0.000345	0.0183	CbGeAlD
Docetaxel—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.000336	0.00884	CcSEcCtD
Docetaxel—Extravasation—Vinblastine—head and neck cancer	0.000326	0.00858	CcSEcCtD
Docetaxel—BCL2—connective tissue—head and neck cancer	0.000318	0.0169	CbGeAlD
Docetaxel—Lacrimation—Fluorouracil—head and neck cancer	0.000318	0.00836	CcSEcCtD
Docetaxel—NR1I2—head—head and neck cancer	0.000315	0.0167	CbGeAlD
Docetaxel—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.000314	0.00826	CcSEcCtD
Docetaxel—KIF11—lymph node—head and neck cancer	0.000313	0.0166	CbGeAlD
Docetaxel—MAP2—parotid gland—head and neck cancer	0.000313	0.0166	CbGeAlD
Docetaxel—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000311	0.00817	CcSEcCtD
Docetaxel—TUBB8—head—head and neck cancer	0.000302	0.016	CbGeAlD
Docetaxel—BCL2—epithelium—head and neck cancer	0.000302	0.016	CbGeAlD
Docetaxel—MAP2—saliva-secreting gland—head and neck cancer	0.0003	0.0159	CbGeAlD
Docetaxel—Bone pain—Vinblastine—head and neck cancer	0.000297	0.00782	CcSEcCtD
Docetaxel—Amenorrhoea—Hydroxyurea—head and neck cancer	0.000295	0.00777	CcSEcCtD
Docetaxel—MAPT—thyroid gland—head and neck cancer	0.000295	0.0157	CbGeAlD
Docetaxel—Nail disorder—Fluorouracil—head and neck cancer	0.000288	0.00758	CcSEcCtD
Docetaxel—CYP1B1—hair follicle—head and neck cancer	0.000273	0.0145	CbGeAlD
Docetaxel—Heartburn—Fluorouracil—head and neck cancer	0.000271	0.00714	CcSEcCtD
Docetaxel—Neoplasm—Vinblastine—head and neck cancer	0.000257	0.00677	CcSEcCtD
Docetaxel—TUBB3—lymphoid tissue—head and neck cancer	0.000256	0.0136	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—head and neck cancer	0.000256	0.0136	CbGeAlD
Docetaxel—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000248	0.00652	CcSEcCtD
Docetaxel—ABCC1—hair follicle—head and neck cancer	0.000246	0.0131	CbGeAlD
Docetaxel—Phlebitis—Vinblastine—head and neck cancer	0.00024	0.00631	CcSEcCtD
Docetaxel—Necrosis—Fluorouracil—head and neck cancer	0.000238	0.00626	CcSEcCtD
Docetaxel—Neoplasm—Hydroxyurea—head and neck cancer	0.000235	0.00617	CcSEcCtD
Docetaxel—TUBB2B—parotid gland—head and neck cancer	0.000234	0.0124	CbGeAlD
Docetaxel—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.000232	0.00611	CcSEcCtD
Docetaxel—BCL2—lymphoid tissue—head and neck cancer	0.000232	0.0124	CbGeAlD
Docetaxel—MAP4—thyroid gland—head and neck cancer	0.000232	0.0123	CbGeAlD
Docetaxel—MAP2—trachea—head and neck cancer	0.000231	0.0123	CbGeAlD
Docetaxel—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.000231	0.00608	CcSEcCtD
Docetaxel—Deafness—Vinblastine—head and neck cancer	0.000231	0.00608	CcSEcCtD
Docetaxel—TUBB2B—saliva-secreting gland—head and neck cancer	0.000224	0.0119	CbGeAlD
Docetaxel—TUBB—parotid gland—head and neck cancer	0.000221	0.0118	CbGeAlD
Docetaxel—TUBB2A—parotid gland—head and neck cancer	0.00022	0.0117	CbGeAlD
Docetaxel—Eye irritation—Fluorouracil—head and neck cancer	0.000219	0.00576	CcSEcCtD
Docetaxel—TUBB6—parotid gland—head and neck cancer	0.000217	0.0115	CbGeAlD
Docetaxel—Extravasation—Fluorouracil—head and neck cancer	0.000214	0.00563	CcSEcCtD
Docetaxel—TUBB4A—connective tissue—head and neck cancer	0.000213	0.0113	CbGeAlD
Docetaxel—TUBB—saliva-secreting gland—head and neck cancer	0.000212	0.0113	CbGeAlD
Docetaxel—BCL2—thyroid gland—head and neck cancer	0.000211	0.0112	CbGeAlD
Docetaxel—TUBB2A—saliva-secreting gland—head and neck cancer	0.000211	0.0112	CbGeAlD
Docetaxel—Hepatic failure—Hydroxyurea—head and neck cancer	0.00021	0.00552	CcSEcCtD
Docetaxel—EGFR—thyroid gland—head and neck cancer	0.000209	0.0111	CbGeAlD
Docetaxel—TUBB6—saliva-secreting gland—head and neck cancer	0.000208	0.011	CbGeAlD
Docetaxel—TUBB3—head—head and neck cancer	0.000206	0.011	CbGeAlD
Docetaxel—MAP4—head—head and neck cancer	0.000206	0.011	CbGeAlD
Docetaxel—TUBB2B—connective tissue—head and neck cancer	0.000206	0.0109	CbGeAlD
Docetaxel—Lacrimation increased—Fluorouracil—head and neck cancer	0.000203	0.00533	CcSEcCtD
Docetaxel—TUBB1—head—head and neck cancer	0.000201	0.0107	CbGeAlD
Docetaxel—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.000197	0.00519	CcSEcCtD
Docetaxel—TUBB2A—connective tissue—head and neck cancer	0.000194	0.0103	CbGeAlD
Docetaxel—Inflammation—Fluorouracil—head and neck cancer	0.000193	0.00507	CcSEcCtD
Docetaxel—ABCC10—parotid gland—head and neck cancer	0.00019	0.0101	CbGeAlD
Docetaxel—TUBB4B—parotid gland—head and neck cancer	0.000189	0.01	CbGeAlD
Docetaxel—BCL2—head—head and neck cancer	0.000187	0.00995	CbGeAlD
Docetaxel—MAPT—lymph node—head and neck cancer	0.000183	0.00975	CbGeAlD
Docetaxel—MAP2—thyroid gland—head and neck cancer	0.000183	0.00972	CbGeAlD
Docetaxel—ABCC10—saliva-secreting gland—head and neck cancer	0.000182	0.00967	CbGeAlD
Docetaxel—TUBB6—epithelium—head and neck cancer	0.000181	0.00964	CbGeAlD
Docetaxel—TUBB4B—saliva-secreting gland—head and neck cancer	0.000181	0.0096	CbGeAlD
Docetaxel—Angina pectoris—Vinblastine—head and neck cancer	0.000174	0.00458	CcSEcCtD
Docetaxel—TUBB2B—trachea—head and neck cancer	0.000173	0.00918	CbGeAlD
Docetaxel—Oesophagitis—Fluorouracil—head and neck cancer	0.000171	0.00449	CcSEcCtD
Docetaxel—Breast disorder—Hydroxyurea—head and neck cancer	0.00017	0.00448	CcSEcCtD
Docetaxel—Pancytopenia—Vinblastine—head and neck cancer	0.00017	0.00446	CcSEcCtD
Docetaxel—TUBB4B—connective tissue—head and neck cancer	0.000166	0.00882	CbGeAlD
Docetaxel—TUBB—trachea—head and neck cancer	0.000163	0.00868	CbGeAlD
Docetaxel—TUBB2A—trachea—head and neck cancer	0.000163	0.00864	CbGeAlD
Docetaxel—MAP2—head—head and neck cancer	0.000162	0.00862	CbGeAlD
Docetaxel—Sepsis—Fluorouracil—head and neck cancer	0.000162	0.00426	CcSEcCtD
Docetaxel—TUBB6—trachea—head and neck cancer	0.00016	0.00852	CbGeAlD
Docetaxel—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000157	0.00413	CcSEcCtD
Docetaxel—Thrombophlebitis—Fluorouracil—head and neck cancer	0.000157	0.00412	CcSEcCtD
Docetaxel—Myocardial infarction—Vinblastine—head and neck cancer	0.000156	0.00411	CcSEcCtD
Docetaxel—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000156	0.00411	CcSEcCtD
Docetaxel—TUBB4A—lymphoid tissue—head and neck cancer	0.000156	0.00827	CbGeAlD
Docetaxel—Pancytopenia—Hydroxyurea—head and neck cancer	0.000155	0.00407	CcSEcCtD
Docetaxel—Swelling—Fluorouracil—head and neck cancer	0.000154	0.00404	CcSEcCtD
Docetaxel—Neutropenia—Hydroxyurea—head and neck cancer	0.000152	0.00401	CcSEcCtD
Docetaxel—Agranulocytosis—Vinblastine—head and neck cancer	0.000149	0.00391	CcSEcCtD
Docetaxel—Weight increased—Hydroxyurea—head and neck cancer	0.000148	0.0039	CcSEcCtD
Docetaxel—Infestation—Hydroxyurea—head and neck cancer	0.000145	0.00382	CcSEcCtD
Docetaxel—Infestation NOS—Hydroxyurea—head and neck cancer	0.000145	0.00382	CcSEcCtD
Docetaxel—MAP4—lymph node—head and neck cancer	0.000144	0.00767	CbGeAlD
Docetaxel—Haemoglobin—Vinblastine—head and neck cancer	0.000144	0.00378	CcSEcCtD
Docetaxel—Haemorrhage—Vinblastine—head and neck cancer	0.000143	0.00376	CcSEcCtD
Docetaxel—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000142	0.00374	CcSEcCtD
Docetaxel—Hypoaesthesia—Vinblastine—head and neck cancer	0.000142	0.00374	CcSEcCtD
Docetaxel—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000142	0.00373	CcSEcCtD
Docetaxel—Pharyngitis—Vinblastine—head and neck cancer	0.000142	0.00373	CcSEcCtD
Docetaxel—Stomatitis—Hydroxyurea—head and neck cancer	0.000142	0.00372	CcSEcCtD
Docetaxel—TUBB4A—thyroid gland—head and neck cancer	0.000141	0.00751	CbGeAlD
Docetaxel—ABCC10—trachea—head and neck cancer	0.00014	0.00746	CbGeAlD
Docetaxel—TUBB6—lymphoid tissue—head and neck cancer	0.00014	0.00742	CbGeAlD
Docetaxel—TUBB4B—trachea—head and neck cancer	0.000139	0.00741	CbGeAlD
Docetaxel—Cardiac failure—Fluorouracil—head and neck cancer	0.000139	0.00366	CcSEcCtD
Docetaxel—Lethargy—Fluorouracil—head and neck cancer	0.000138	0.00364	CcSEcCtD
Docetaxel—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000137	0.00361	CcSEcCtD
Docetaxel—TUBB2B—thyroid gland—head and neck cancer	0.000137	0.00726	CbGeAlD
Docetaxel—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000136	0.00357	CcSEcCtD
Docetaxel—ABCC1—parotid gland—head and neck cancer	0.000134	0.00714	CbGeAlD
Docetaxel—CYP1B1—connective tissue—head and neck cancer	0.000131	0.00699	CbGeAlD
Docetaxel—BCL2—lymph node—head and neck cancer	0.000131	0.00697	CbGeAlD
Docetaxel—Haemoglobin—Hydroxyurea—head and neck cancer	0.000131	0.00345	CcSEcCtD
Docetaxel—Haemorrhage—Hydroxyurea—head and neck cancer	0.00013	0.00343	CcSEcCtD
Docetaxel—EGFR—lymph node—head and neck cancer	0.00013	0.00689	CbGeAlD
Docetaxel—TUBB—thyroid gland—head and neck cancer	0.000129	0.00687	CbGeAlD
Docetaxel—TUBB2A—thyroid gland—head and neck cancer	0.000129	0.00683	CbGeAlD
Docetaxel—Ataxia—Fluorouracil—head and neck cancer	0.000128	0.00335	CcSEcCtD
Docetaxel—TUBB6—thyroid gland—head and neck cancer	0.000127	0.00674	CbGeAlD
Docetaxel—Alopecia—Vinblastine—head and neck cancer	0.000126	0.00332	CcSEcCtD
Docetaxel—TUBB4A—head—head and neck cancer	0.000125	0.00666	CbGeAlD
Docetaxel—Dry skin—Fluorouracil—head and neck cancer	0.000124	0.00327	CcSEcCtD
Docetaxel—ABCC10—lymphoid tissue—head and neck cancer	0.000122	0.0065	CbGeAlD
Docetaxel—TUBB4B—lymphoid tissue—head and neck cancer	0.000121	0.00645	CbGeAlD
Docetaxel—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000121	0.00319	CcSEcCtD
Docetaxel—TUBB2B—head—head and neck cancer	0.000121	0.00644	CbGeAlD
Docetaxel—Angiopathy—Hydroxyurea—head and neck cancer	0.000118	0.00311	CcSEcCtD
Docetaxel—Dysphagia—Fluorouracil—head and neck cancer	0.000117	0.00308	CcSEcCtD
Docetaxel—Chills—Hydroxyurea—head and neck cancer	0.000117	0.00308	CcSEcCtD
Docetaxel—Alopecia—Hydroxyurea—head and neck cancer	0.000115	0.00303	CcSEcCtD
Docetaxel—Anaemia—Vinblastine—head and neck cancer	0.000115	0.00303	CcSEcCtD
Docetaxel—Angina pectoris—Fluorouracil—head and neck cancer	0.000114	0.003	CcSEcCtD
Docetaxel—TUBB2A—head—head and neck cancer	0.000114	0.00606	CbGeAlD
Docetaxel—MAP2—lymph node—head and neck cancer	0.000114	0.00604	CbGeAlD
Docetaxel—Erythema—Hydroxyurea—head and neck cancer	0.000113	0.00298	CcSEcCtD
Docetaxel—TUBB6—head—head and neck cancer	0.000112	0.00598	CbGeAlD
Docetaxel—Leukopenia—Vinblastine—head and neck cancer	0.000111	0.00293	CcSEcCtD
Docetaxel—Pancytopenia—Fluorouracil—head and neck cancer	0.000111	0.00293	CcSEcCtD
Docetaxel—ABCG2—parotid gland—head and neck cancer	0.000111	0.00591	CbGeAlD
Docetaxel—ABCC10—thyroid gland—head and neck cancer	0.000111	0.0059	CbGeAlD
Docetaxel—TUBB4B—thyroid gland—head and neck cancer	0.00011	0.00586	CbGeAlD
Docetaxel—Convulsion—Vinblastine—head and neck cancer	0.000108	0.00284	CcSEcCtD
Docetaxel—Hypertension—Vinblastine—head and neck cancer	0.000107	0.00283	CcSEcCtD
Docetaxel—ABCG2—saliva-secreting gland—head and neck cancer	0.000107	0.00566	CbGeAlD
Docetaxel—Pneumonia—Fluorouracil—head and neck cancer	0.000105	0.00277	CcSEcCtD
Docetaxel—Anaemia—Hydroxyurea—head and neck cancer	0.000105	0.00276	CcSEcCtD
Docetaxel—Infestation—Fluorouracil—head and neck cancer	0.000105	0.00275	CcSEcCtD
Docetaxel—Infestation NOS—Fluorouracil—head and neck cancer	0.000105	0.00275	CcSEcCtD
Docetaxel—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000103	0.00271	CcSEcCtD
Docetaxel—Myocardial infarction—Fluorouracil—head and neck cancer	0.000102	0.00269	CcSEcCtD
Docetaxel—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000102	0.00269	CcSEcCtD
Docetaxel—Stomatitis—Fluorouracil—head and neck cancer	0.000102	0.00268	CcSEcCtD
Docetaxel—Conjunctivitis—Fluorouracil—head and neck cancer	0.000102	0.00267	CcSEcCtD
Docetaxel—Leukopenia—Hydroxyurea—head and neck cancer	0.000102	0.00267	CcSEcCtD
Docetaxel—Thrombocytopenia—Vinblastine—head and neck cancer	9.94e-05	0.00262	CcSEcCtD
Docetaxel—ABCC1—trachea—head and neck cancer	9.93e-05	0.00528	CbGeAlD
Docetaxel—Epistaxis—Fluorouracil—head and neck cancer	9.86e-05	0.00259	CcSEcCtD
Docetaxel—Convulsion—Hydroxyurea—head and neck cancer	9.83e-05	0.00259	CcSEcCtD
Docetaxel—TUBB4B—head—head and neck cancer	9.78e-05	0.0052	CbGeAlD
Docetaxel—Agranulocytosis—Fluorouracil—head and neck cancer	9.75e-05	0.00257	CcSEcCtD
Docetaxel—Anorexia—Vinblastine—head and neck cancer	9.68e-05	0.00255	CcSEcCtD
Docetaxel—CYP1B1—lymphoid tissue—head and neck cancer	9.61e-05	0.00511	CbGeAlD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	9.59e-05	0.00252	CcSEcCtD
Docetaxel—Haemoglobin—Fluorouracil—head and neck cancer	9.43e-05	0.00248	CcSEcCtD
Docetaxel—Rhinitis—Fluorouracil—head and neck cancer	9.41e-05	0.00247	CcSEcCtD
Docetaxel—Haemorrhage—Fluorouracil—head and neck cancer	9.38e-05	0.00247	CcSEcCtD
Docetaxel—Hypoaesthesia—Fluorouracil—head and neck cancer	9.34e-05	0.00246	CcSEcCtD
Docetaxel—Pharyngitis—Fluorouracil—head and neck cancer	9.31e-05	0.00245	CcSEcCtD
Docetaxel—Oedema—Hydroxyurea—head and neck cancer	9.26e-05	0.00244	CcSEcCtD
Docetaxel—Infection—Hydroxyurea—head and neck cancer	9.2e-05	0.00242	CcSEcCtD
Docetaxel—Paraesthesia—Vinblastine—head and neck cancer	9.12e-05	0.0024	CcSEcCtD
Docetaxel—Nervous system disorder—Hydroxyurea—head and neck cancer	9.08e-05	0.00239	CcSEcCtD
Docetaxel—Thrombocytopenia—Hydroxyurea—head and neck cancer	9.07e-05	0.00239	CcSEcCtD
Docetaxel—Skin disorder—Hydroxyurea—head and neck cancer	9e-05	0.00237	CcSEcCtD
Docetaxel—Anorexia—Hydroxyurea—head and neck cancer	8.83e-05	0.00232	CcSEcCtD
Docetaxel—Decreased appetite—Vinblastine—head and neck cancer	8.83e-05	0.00232	CcSEcCtD
Docetaxel—TUBB4A—lymph node—head and neck cancer	8.78e-05	0.00467	CbGeAlD
Docetaxel—CYP1B1—thyroid gland—head and neck cancer	8.73e-05	0.00464	CbGeAlD
Docetaxel—Constipation—Vinblastine—head and neck cancer	8.68e-05	0.00228	CcSEcCtD
Docetaxel—Pain—Vinblastine—head and neck cancer	8.68e-05	0.00228	CcSEcCtD
Docetaxel—TUBB2B—lymph node—head and neck cancer	8.48e-05	0.00451	CbGeAlD
Docetaxel—Arrhythmia—Fluorouracil—head and neck cancer	8.38e-05	0.0022	CcSEcCtD
Docetaxel—Feeling abnormal—Vinblastine—head and neck cancer	8.37e-05	0.0022	CcSEcCtD
Docetaxel—Gastrointestinal pain—Vinblastine—head and neck cancer	8.3e-05	0.00218	CcSEcCtD
Docetaxel—Alopecia—Fluorouracil—head and neck cancer	8.29e-05	0.00218	CcSEcCtD
Docetaxel—Dyspnoea—Hydroxyurea—head and neck cancer	8.26e-05	0.00217	CcSEcCtD
Docetaxel—Somnolence—Hydroxyurea—head and neck cancer	8.23e-05	0.00217	CcSEcCtD
Docetaxel—Erythema—Fluorouracil—head and neck cancer	8.17e-05	0.00215	CcSEcCtD
Docetaxel—Dyspepsia—Hydroxyurea—head and neck cancer	8.15e-05	0.00214	CcSEcCtD
Docetaxel—Decreased appetite—Hydroxyurea—head and neck cancer	8.05e-05	0.00212	CcSEcCtD
Docetaxel—TUBB—lymph node—head and neck cancer	8.03e-05	0.00427	CbGeAlD
Docetaxel—Abdominal pain—Vinblastine—head and neck cancer	8.03e-05	0.00211	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	8e-05	0.0021	CcSEcCtD
Docetaxel—TUBB2A—lymph node—head and neck cancer	7.99e-05	0.00425	CbGeAlD
Docetaxel—Fatigue—Hydroxyurea—head and neck cancer	7.98e-05	0.0021	CcSEcCtD
Docetaxel—Pain—Hydroxyurea—head and neck cancer	7.92e-05	0.00208	CcSEcCtD
Docetaxel—Constipation—Hydroxyurea—head and neck cancer	7.92e-05	0.00208	CcSEcCtD
Docetaxel—TUBB6—lymph node—head and neck cancer	7.88e-05	0.00419	CbGeAlD
Docetaxel—ABCC1—thyroid gland—head and neck cancer	7.85e-05	0.00417	CbGeAlD
Docetaxel—CYP1B1—head—head and neck cancer	7.75e-05	0.00412	CbGeAlD
Docetaxel—Feeling abnormal—Hydroxyurea—head and neck cancer	7.63e-05	0.00201	CcSEcCtD
Docetaxel—Anaemia—Fluorouracil—head and neck cancer	7.55e-05	0.00199	CcSEcCtD
Docetaxel—Hypersensitivity—Vinblastine—head and neck cancer	7.48e-05	0.00197	CcSEcCtD
Docetaxel—Body temperature increased—Hydroxyurea—head and neck cancer	7.32e-05	0.00193	CcSEcCtD
Docetaxel—Leukopenia—Fluorouracil—head and neck cancer	7.31e-05	0.00192	CcSEcCtD
Docetaxel—Asthenia—Vinblastine—head and neck cancer	7.29e-05	0.00192	CcSEcCtD
Docetaxel—Convulsion—Fluorouracil—head and neck cancer	7.08e-05	0.00186	CcSEcCtD
Docetaxel—Chest pain—Fluorouracil—head and neck cancer	6.95e-05	0.00183	CcSEcCtD
Docetaxel—Myalgia—Fluorouracil—head and neck cancer	6.95e-05	0.00183	CcSEcCtD
Docetaxel—Diarrhoea—Vinblastine—head and neck cancer	6.95e-05	0.00183	CcSEcCtD
Docetaxel—ABCC10—lymph node—head and neck cancer	6.9e-05	0.00367	CbGeAlD
Docetaxel—TUBB4B—lymph node—head and neck cancer	6.85e-05	0.00364	CbGeAlD
Docetaxel—Hypersensitivity—Hydroxyurea—head and neck cancer	6.82e-05	0.00179	CcSEcCtD
Docetaxel—Confusional state—Fluorouracil—head and neck cancer	6.72e-05	0.00177	CcSEcCtD
Docetaxel—Dizziness—Vinblastine—head and neck cancer	6.72e-05	0.00177	CcSEcCtD
Docetaxel—Anaphylactic shock—Fluorouracil—head and neck cancer	6.67e-05	0.00175	CcSEcCtD
Docetaxel—Oedema—Fluorouracil—head and neck cancer	6.67e-05	0.00175	CcSEcCtD
Docetaxel—Asthenia—Hydroxyurea—head and neck cancer	6.64e-05	0.00175	CcSEcCtD
Docetaxel—Infection—Fluorouracil—head and neck cancer	6.62e-05	0.00174	CcSEcCtD
Docetaxel—Nervous system disorder—Fluorouracil—head and neck cancer	6.54e-05	0.00172	CcSEcCtD
Docetaxel—Thrombocytopenia—Fluorouracil—head and neck cancer	6.53e-05	0.00172	CcSEcCtD
Docetaxel—Tachycardia—Fluorouracil—head and neck cancer	6.51e-05	0.00171	CcSEcCtD
Docetaxel—ABCG2—thyroid gland—head and neck cancer	6.5e-05	0.00346	CbGeAlD
Docetaxel—Vomiting—Vinblastine—head and neck cancer	6.46e-05	0.0017	CcSEcCtD
Docetaxel—Headache—Vinblastine—head and neck cancer	6.36e-05	0.00167	CcSEcCtD
Docetaxel—Anorexia—Fluorouracil—head and neck cancer	6.35e-05	0.00167	CcSEcCtD
Docetaxel—Diarrhoea—Hydroxyurea—head and neck cancer	6.34e-05	0.00167	CcSEcCtD
Docetaxel—Hypotension—Fluorouracil—head and neck cancer	6.23e-05	0.00164	CcSEcCtD
Docetaxel—Dizziness—Hydroxyurea—head and neck cancer	6.12e-05	0.00161	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	6.07e-05	0.0016	CcSEcCtD
Docetaxel—Nausea—Vinblastine—head and neck cancer	6.03e-05	0.00159	CcSEcCtD
Docetaxel—Insomnia—Fluorouracil—head and neck cancer	6.03e-05	0.00159	CcSEcCtD
Docetaxel—Paraesthesia—Fluorouracil—head and neck cancer	5.99e-05	0.00157	CcSEcCtD
Docetaxel—Dyspnoea—Fluorouracil—head and neck cancer	5.94e-05	0.00156	CcSEcCtD
Docetaxel—Somnolence—Fluorouracil—head and neck cancer	5.93e-05	0.00156	CcSEcCtD
Docetaxel—Vomiting—Hydroxyurea—head and neck cancer	5.89e-05	0.00155	CcSEcCtD
Docetaxel—Dyspepsia—Fluorouracil—head and neck cancer	5.87e-05	0.00154	CcSEcCtD
Docetaxel—Rash—Hydroxyurea—head and neck cancer	5.84e-05	0.00154	CcSEcCtD
Docetaxel—Dermatitis—Hydroxyurea—head and neck cancer	5.83e-05	0.00153	CcSEcCtD
Docetaxel—Headache—Hydroxyurea—head and neck cancer	5.8e-05	0.00153	CcSEcCtD
Docetaxel—Decreased appetite—Fluorouracil—head and neck cancer	5.79e-05	0.00152	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Fluorouracil—head and neck cancer	5.75e-05	0.00151	CcSEcCtD
Docetaxel—Pain—Fluorouracil—head and neck cancer	5.7e-05	0.0015	CcSEcCtD
Docetaxel—ABCC2—lymph node—head and neck cancer	5.54e-05	0.00294	CbGeAlD
Docetaxel—Nausea—Hydroxyurea—head and neck cancer	5.5e-05	0.00145	CcSEcCtD
Docetaxel—Feeling abnormal—Fluorouracil—head and neck cancer	5.49e-05	0.00144	CcSEcCtD
Docetaxel—CYP1B1—lymph node—head and neck cancer	5.42e-05	0.00288	CbGeAlD
Docetaxel—Body temperature increased—Fluorouracil—head and neck cancer	5.27e-05	0.00139	CcSEcCtD
Docetaxel—Hypersensitivity—Fluorouracil—head and neck cancer	4.91e-05	0.00129	CcSEcCtD
Docetaxel—ABCC1—lymph node—head and neck cancer	4.88e-05	0.00259	CbGeAlD
Docetaxel—Pruritus—Fluorouracil—head and neck cancer	4.72e-05	0.00124	CcSEcCtD
Docetaxel—ABCB1—epithelium—head and neck cancer	4.58e-05	0.00244	CbGeAlD
Docetaxel—Diarrhoea—Fluorouracil—head and neck cancer	4.56e-05	0.0012	CcSEcCtD
Docetaxel—Dizziness—Fluorouracil—head and neck cancer	4.41e-05	0.00116	CcSEcCtD
Docetaxel—Vomiting—Fluorouracil—head and neck cancer	4.24e-05	0.00111	CcSEcCtD
Docetaxel—Rash—Fluorouracil—head and neck cancer	4.2e-05	0.00111	CcSEcCtD
Docetaxel—Dermatitis—Fluorouracil—head and neck cancer	4.2e-05	0.0011	CcSEcCtD
Docetaxel—Headache—Fluorouracil—head and neck cancer	4.18e-05	0.0011	CcSEcCtD
Docetaxel—ABCB1—trachea—head and neck cancer	4.05e-05	0.00215	CbGeAlD
Docetaxel—ABCG2—lymph node—head and neck cancer	4.04e-05	0.00215	CbGeAlD
Docetaxel—Nausea—Fluorouracil—head and neck cancer	3.96e-05	0.00104	CcSEcCtD
Docetaxel—ABCB1—lymphoid tissue—head and neck cancer	3.53e-05	0.00188	CbGeAlD
Docetaxel—ABCB1—thyroid gland—head and neck cancer	3.21e-05	0.0017	CbGeAlD
Docetaxel—ABCB1—head—head and neck cancer	2.84e-05	0.00151	CbGeAlD
Docetaxel—ABCB1—lymph node—head and neck cancer	1.99e-05	0.00106	CbGeAlD
Docetaxel—EGFR—B Cell Activation—PIK3CA—head and neck cancer	7.48e-06	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—head and neck cancer	7.48e-06	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—head and neck cancer	7.48e-06	0.000191	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—head and neck cancer	7.48e-06	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—AKT1—head and neck cancer	7.46e-06	0.00019	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—DPYD—head and neck cancer	7.43e-06	0.00019	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	7.42e-06	0.000189	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—head and neck cancer	7.41e-06	0.000189	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MAPK3—head and neck cancer	7.41e-06	0.000189	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	7.36e-06	0.000188	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—head and neck cancer	7.35e-06	0.000187	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	7.34e-06	0.000187	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—head and neck cancer	7.32e-06	0.000187	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	7.32e-06	0.000187	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—YAP1—head and neck cancer	7.29e-06	0.000186	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MAPK3—head and neck cancer	7.24e-06	0.000185	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	7.16e-06	0.000183	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—AKT1—head and neck cancer	7.13e-06	0.000182	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—AKT1—head and neck cancer	7.09e-06	0.000181	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—AKT1—head and neck cancer	7.09e-06	0.000181	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—head and neck cancer	7.07e-06	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—AKT1—head and neck cancer	7.06e-06	0.00018	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—YAP1—head and neck cancer	7.05e-06	0.00018	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MAPK1—head and neck cancer	7.05e-06	0.00018	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	7.03e-06	0.000179	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—AKT1—head and neck cancer	7.02e-06	0.000179	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—STAT3—head and neck cancer	6.98e-06	0.000178	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—head and neck cancer	6.98e-06	0.000178	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	6.94e-06	0.000177	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—head and neck cancer	6.92e-06	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	6.92e-06	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	6.92e-06	0.000177	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MAPK1—head and neck cancer	6.89e-06	0.000176	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—AKT1—head and neck cancer	6.89e-06	0.000176	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—DPYD—head and neck cancer	6.76e-06	0.000172	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.76e-06	0.000172	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—DPYD—head and neck cancer	6.7e-06	0.000171	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GRP—head and neck cancer	6.69e-06	0.000171	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—MAPK3—head and neck cancer	6.67e-06	0.00017	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	6.63e-06	0.000169	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MAPK3—head and neck cancer	6.63e-06	0.000169	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—AKT1—head and neck cancer	6.61e-06	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	6.61e-06	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—AKT1—head and neck cancer	6.61e-06	0.000169	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	6.57e-06	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—AKT1—head and neck cancer	6.55e-06	0.000167	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—PIK3CA—head and neck cancer	6.51e-06	0.000166	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT6—head and neck cancer	6.49e-06	0.000166	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—AKT1—head and neck cancer	6.49e-06	0.000166	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—AKT1—head and neck cancer	6.46e-06	0.000165	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—MAPK3—head and neck cancer	6.44e-06	0.000164	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—YAP1—head and neck cancer	6.42e-06	0.000164	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	6.4e-06	0.000163	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—VEGFA—head and neck cancer	6.38e-06	0.000163	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—YAP1—head and neck cancer	6.36e-06	0.000162	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—MAPK1—head and neck cancer	6.35e-06	0.000162	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MAPK1—head and neck cancer	6.3e-06	0.000161	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—head and neck cancer	6.3e-06	0.000161	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CASP8—head and neck cancer	6.26e-06	0.00016	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.24e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—AKT1—head and neck cancer	6.24e-06	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	6.22e-06	0.000159	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—TYMS—head and neck cancer	6.19e-06	0.000158	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—UROD—head and neck cancer	6.19e-06	0.000158	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CASP8—head and neck cancer	6.17e-06	0.000157	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—MAPK1—head and neck cancer	6.12e-06	0.000156	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—head and neck cancer	6.12e-06	0.000156	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GSTM1—head and neck cancer	6.12e-06	0.000156	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—AKT1—head and neck cancer	6.11e-06	0.000156	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDH1—head and neck cancer	6.1e-06	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MAPK3—head and neck cancer	6.04e-06	0.000154	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—head and neck cancer	6.03e-06	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDH1—head and neck cancer	5.94e-06	0.000152	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—MAPK3—head and neck cancer	5.92e-06	0.000151	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GPX1—head and neck cancer	5.86e-06	0.00015	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	5.85e-06	0.000149	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CYP1A1—head and neck cancer	5.8e-06	0.000148	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—head and neck cancer	5.79e-06	0.000148	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—YAP1—head and neck cancer	5.75e-06	0.000147	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MAPK1—head and neck cancer	5.74e-06	0.000147	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	5.64e-06	0.000144	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NAT2—head and neck cancer	5.52e-06	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—PIK3CA—head and neck cancer	5.51e-06	0.000141	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.48e-06	0.00014	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.44e-06	0.000139	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—BCL2—head and neck cancer	5.38e-06	0.000137	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AKT1—head and neck cancer	5.32e-06	0.000136	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—PIK3CA—head and neck cancer	5.31e-06	0.000136	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.3e-06	0.000135	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—head and neck cancer	5.29e-06	0.000135	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—head and neck cancer	5.1e-06	0.00013	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.92e-06	0.000125	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—head and neck cancer	4.92e-06	0.000125	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—DPYD—head and neck cancer	4.84e-06	0.000124	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.78e-06	0.000122	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.77e-06	0.000122	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2—head and neck cancer	4.66e-06	0.000119	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.65e-06	0.000119	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.62e-06	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—head and neck cancer	4.61e-06	0.000118	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—YAP1—head and neck cancer	4.6e-06	0.000117	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—head and neck cancer	4.55e-06	0.000116	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—STAT3—head and neck cancer	4.51e-06	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—head and neck cancer	4.5e-06	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2L1—head and neck cancer	4.46e-06	0.000114	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PTEN—head and neck cancer	4.45e-06	0.000114	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.43e-06	0.000113	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.42e-06	0.000113	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PTEN—head and neck cancer	4.39e-06	0.000112	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TYMS—head and neck cancer	4.38e-06	0.000112	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—head and neck cancer	4.34e-06	0.000111	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GSTM1—head and neck cancer	4.33e-06	0.00011	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MAPK3—head and neck cancer	4.31e-06	0.00011	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PTEN—head and neck cancer	4.28e-06	0.000109	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TYMS—head and neck cancer	4.23e-06	0.000108	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GSTM1—head and neck cancer	4.19e-06	0.000107	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NAT2—head and neck cancer	4.17e-06	0.000106	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GPX1—head and neck cancer	4.14e-06	0.000106	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP1A1—head and neck cancer	4.1e-06	0.000105	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MAPK1—head and neck cancer	4.1e-06	0.000105	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GPX1—head and neck cancer	4.01e-06	0.000102	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—head and neck cancer	4e-06	0.000102	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP1A1—head and neck cancer	3.97e-06	0.000101	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOTCH1—head and neck cancer	3.92e-06	0.0001	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—head and neck cancer	3.92e-06	0.0001	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TYMS—head and neck cancer	3.85e-06	9.83e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.84e-06	9.8e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TYMS—head and neck cancer	3.82e-06	9.74e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTM1—head and neck cancer	3.81e-06	9.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK3—head and neck cancer	3.81e-06	9.71e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTM1—head and neck cancer	3.77e-06	9.63e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK3—head and neck cancer	3.75e-06	9.56e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.71e-06	9.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOTCH1—head and neck cancer	3.7e-06	9.44e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—DPYD—head and neck cancer	3.66e-06	9.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CASP8—head and neck cancer	3.65e-06	9.31e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GPX1—head and neck cancer	3.65e-06	9.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK1—head and neck cancer	3.62e-06	9.24e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GPX1—head and neck cancer	3.61e-06	9.22e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP1A1—head and neck cancer	3.61e-06	9.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—head and neck cancer	3.61e-06	9.2e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP1A1—head and neck cancer	3.58e-06	9.13e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK1—head and neck cancer	3.57e-06	9.1e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—head and neck cancer	3.57e-06	9.1e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—YAP1—head and neck cancer	3.47e-06	8.85e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—head and neck cancer	3.45e-06	8.8e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.37e-06	8.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—head and neck cancer	3.29e-06	8.4e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.26e-06	8.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—head and neck cancer	3.14e-06	8.02e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.14e-06	8e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2—head and neck cancer	3.13e-06	7.99e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—head and neck cancer	3.1e-06	7.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—head and neck cancer	3.02e-06	7.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—head and neck cancer	3.02e-06	7.7e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—head and neck cancer	3.01e-06	7.68e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—head and neck cancer	2.91e-06	7.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—head and neck cancer	2.91e-06	7.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—head and neck cancer	2.91e-06	7.41e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—head and neck cancer	2.86e-06	7.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—head and neck cancer	2.79e-06	7.12e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TYMS—head and neck cancer	2.76e-06	7.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—head and neck cancer	2.76e-06	7.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—head and neck cancer	2.75e-06	7.01e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—head and neck cancer	2.73e-06	6.96e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GPX1—head and neck cancer	2.61e-06	6.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—head and neck cancer	2.59e-06	6.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH1—head and neck cancer	2.59e-06	6.61e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1A1—head and neck cancer	2.59e-06	6.6e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NAT2—head and neck cancer	2.57e-06	6.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—head and neck cancer	2.57e-06	6.55e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—head and neck cancer	2.54e-06	6.48e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—head and neck cancer	2.53e-06	6.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—head and neck cancer	2.46e-06	6.29e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—head and neck cancer	2.44e-06	6.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK3—head and neck cancer	2.43e-06	6.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—head and neck cancer	2.39e-06	6.11e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—head and neck cancer	2.36e-06	6.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—head and neck cancer	2.32e-06	5.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK1—head and neck cancer	2.31e-06	5.89e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—head and neck cancer	2.27e-06	5.8e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—DPYD—head and neck cancer	2.25e-06	5.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK3—head and neck cancer	2.22e-06	5.65e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK3—head and neck cancer	2.17e-06	5.54e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—head and neck cancer	2.15e-06	5.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—head and neck cancer	2.14e-06	5.46e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—YAP1—head and neck cancer	2.14e-06	5.45e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—head and neck cancer	2.13e-06	5.43e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—head and neck cancer	2.13e-06	5.43e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—head and neck cancer	2.12e-06	5.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK1—head and neck cancer	2.11e-06	5.38e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TYMS—head and neck cancer	2.08e-06	5.31e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK1—head and neck cancer	2.07e-06	5.27e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—head and neck cancer	2.07e-06	5.27e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—head and neck cancer	2.06e-06	5.25e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—head and neck cancer	2.06e-06	5.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK3—head and neck cancer	2.05e-06	5.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—head and neck cancer	2e-06	5.11e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GPX1—head and neck cancer	1.97e-06	5.03e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.95e-06	4.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK1—head and neck cancer	1.95e-06	4.97e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—head and neck cancer	1.87e-06	4.78e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—head and neck cancer	1.86e-06	4.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—head and neck cancer	1.85e-06	4.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—head and neck cancer	1.83e-06	4.67e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—head and neck cancer	1.79e-06	4.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—head and neck cancer	1.78e-06	4.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—head and neck cancer	1.74e-06	4.43e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—head and neck cancer	1.73e-06	4.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—head and neck cancer	1.69e-06	4.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—head and neck cancer	1.69e-06	4.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—head and neck cancer	1.68e-06	4.28e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—head and neck cancer	1.66e-06	4.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—head and neck cancer	1.64e-06	4.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—head and neck cancer	1.56e-06	3.99e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.54e-06	3.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—head and neck cancer	1.51e-06	3.86e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—head and neck cancer	1.5e-06	3.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—head and neck cancer	1.5e-06	3.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—head and neck cancer	1.49e-06	3.81e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—head and neck cancer	1.46e-06	3.74e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—head and neck cancer	1.45e-06	3.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK3—head and neck cancer	1.43e-06	3.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—head and neck cancer	1.38e-06	3.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK1—head and neck cancer	1.36e-06	3.48e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—head and neck cancer	1.34e-06	3.42e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.32e-06	3.37e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.31e-06	3.34e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMS—head and neck cancer	1.28e-06	3.27e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.27e-06	3.24e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—head and neck cancer	1.23e-06	3.13e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPX1—head and neck cancer	1.21e-06	3.1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.2e-06	3.07e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—head and neck cancer	1.19e-06	3.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—head and neck cancer	1.18e-06	3.02e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—head and neck cancer	1.16e-06	2.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—head and neck cancer	1.14e-06	2.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—head and neck cancer	1.09e-06	2.79e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—head and neck cancer	1.08e-06	2.75e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—head and neck cancer	1.07e-06	2.73e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—head and neck cancer	1.01e-06	2.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—head and neck cancer	9.66e-07	2.47e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—head and neck cancer	9.46e-07	2.41e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—head and neck cancer	7.73e-07	1.97e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.15e-07	1.82e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—head and neck cancer	7.14e-07	1.82e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—head and neck cancer	6.24e-07	1.59e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—head and neck cancer	5.83e-07	1.49e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.4e-07	1.12e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—head and neck cancer	3.59e-07	9.17e-06	CbGpPWpGaD
